Abstract: A neuroprotective mixture includes Phosphocreatine (PCr), Magnesium Gluconate (MgG), and ß-hydroxybutyrate (BHB). The PCR, MgG, and BHB are combined in a 2:1:2 molar ratio of PCr:MgH:BHB. The neuroprotective mixture is a useful preventative and prophylactic supplement, which also can function to extend the post-stroke treatment window.

Abstract: A neuroprotective mixture includes Phosphocreatine (PCr), Magnesium Gluconate (MgG), and ?-hydroxybutyrate (BHB). The PCR, MgG, and BHB are combined in a 2:1:2 molar ratio of PCr:MgH:BHB. The neuroprotective mixture is a useful preventative and prophylactic supplement, which also can function to extend the post-stroke treatment window.

Abstract: A first embodiment is a dry eyed animal model method by peri or post-menopausal estrogen-treated rats have decreased tear production wherein the menopausal rat may be produced by ovariectomy Chronic estrogen exposure can decrease tear production in rats receiving a nine month course of estrogen versus placebo treatment after ovariectomy. The aged, chronically estrogen-treated female rats can provide a suitable model for the study of KCS and its treatment.

Abstract: The propulsion system includes a battery powered or combustion powered prime mover and a secondary or auxiliary mover. When the prime mover is battery powered, the secondary mover is controlled so as to optimize the use of the electrical energy stored in the batteries, while using the secondary mover, when necessary, to supply auxiliary power when required for vehicle performance. This is done by keeping the prime mover operating, primarily, in the low to moderate current range, where energy loss in the battery is low and controlling the secondary mover to supply as much power as is necessary to keep the battery drain as near as possible to a preselected threshold value. When the prime mover is combustion powered, the secondary mover is similarly controlled to keep the prime mover within the torque range of most efficient operation.